Stop At One Stockholm (SAOS)- Secondary Fracture Prevention Through Active Patient Identification and Staff Education.
NCT ID: NCT04565743
Last Updated: 2025-03-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
3600 participants
INTERVENTIONAL
2018-02-01
2027-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The design is Cluster-randomized controlled study with two arms. 40 primary health care centers (PHCC) are included, each PHCC constitutes a cluster. The intervention group contains 20 PHCCs and the control group of the remaining 20 PHCCs. The educational part of the intervention is divided into three sessions; one web based course succeeded by two multiprofessional seminars with six months interval. During the intervention period patients enlisted at the intervention PHCCs, aged 60 or more who are diagnosed on a fragility fracture are referred to their respective PHCC. The primary outcome are the proportions of patients who receive bone specific treatment after their fracture in the intervention group compared to the control group.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Digital Education for Osteoporosis Patients on Fracture Risk and Related Health Outcomes.
NCT06603545
A Study to Improve the Collaboration Between Primary and Secondary Health Care on the Treatment of Osteoporosis After a Hip Fracture.
NCT05904353
Primary Care Based Intervention for the Secondary Prevention of Osteoporotic Fractures
NCT03044015
Osteoporosis School
NCT00224991
Education for Osteoporosis in Persons With Existing Fractures
NCT00575250
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The educational intervention targets general practitioners and nurses from the PHCC as well as physiotherapists, occupational therapists and dietitians from a nearby rehabilitation centre.
All professions go through the same web course before educational session #1 which is held at the PHCC. The web course includes basic knowledge about risk factors for fragility fractures
At session #1 all professions first participate in a common seminar of 45 minutes. After that physicians, nurses and rehabilitation related professions each have an additional seminar of 45 minutes, that means three separate seminars. Three teachers lead the seminars; a specialist in family medicine, a nurse specialized in primary care and a physiotherapist. They are all present during all of the seminars at each PHCC and the same three individuals leads the seminars at all PHCCs. The seminars focus on identification of persons at high risk of fracture and different methods to lower that risk. The importance of multiprofessional care for these patients is stressed. The participants are given opportunity to discuss how they might facilitate cooperation between the different health vare professions. Development of local routines for multiprofessional care is encouraged.
Educational session #2 is held approximally 6 months after session #1. Session #2 invites the same health care professionals as session #1. There are three parts. A first part of 45 minutes for the physicians and nurses. A second part of 45 minutes where personnel from the rehabilitation center joins. The third part of 45 minutes includes just the rehabilitation personnel.
At session #2 includes a short review of the contents discussed in session #1. The focus however is on the development of new local routines to secure the ability for patients with a high risk of fracture to be offered multiprofessional care. What needs to be done and who does what at your PHCC/rehabilitation center? The participants also get feedback on the number of patients being treated with bone-specific drugs before and after the start of the intervention.
Inclusion of patients stops at december 1 2020. Referrals to the PHCC of the patients included last will be conducted during January 2021.
Primary outcome data is gathered at each PHCC from the medical journals of the enlisted patients aged \>60 with fragility fractures. Data includes the time frame one year before start of study, until two years after the last patient was included.
Secondary outcomes, fractures and fall related injuries will be collected from National health care registers, three and five years after the last patient was included.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
Multiprofessional education for health professionals in primary care on secondary prevention of osteoporotic fractures. Identification and referral of patients with recent osteoporotic fracture.
Support on dentification and treatment of patients with high risk of osteoporotic fractures
Education for primary care health care professionals and referral of patients with recent osteoporotic fracture.
Control
No intervention from study. No restrictions regarding education or the local organization of care for the prevention of osteoporotic fractures.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Support on dentification and treatment of patients with high risk of osteoporotic fractures
Education for primary care health care professionals and referral of patients with recent osteoporotic fracture.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient is enlisted at one of the PHCCs in the interventional arm of the study
* Patent is aged 60 years or older
Exclusion Criteria
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Region Stockholm
OTHER_GOV
Helena Salminen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Helena Salminen
Associate professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Helena Salminen, MD, Ass Prof
Role: PRINCIPAL_INVESTIGATOR
Karolinska Institutet
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Karolinska Instititet
Huddinge, Stockholm County, Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018/927-31/2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.